Cargando…
Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review
Introduction Increased virulence, the severity of illness, and mortality have all been hypothesized with respect to angiotensin-converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB) use in coronavirus disease 2019 (COVID-19) infection. Our study aims to assess whether ACEi/ARB use in...
Autores principales: | Hassib, Mohab, Hamilton, Steven, Elkhouly, Ahmed, Li, Yiting, Kaplan, Adam C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936537/ https://www.ncbi.nlm.nih.gov/pubmed/33728141 http://dx.doi.org/10.7759/cureus.13124 |
Ejemplares similares
-
A Case of Dronedarone-Induced Hypotensive Shock
por: Hassib, Mohab, et al.
Publicado: (2020) -
A Rare Case of Loperamide-Induced Cardiac Arrest
por: Kapaganti, Sowjanya, et al.
Publicado: (2020) -
An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers
por: Maideen, Naina Mohamed Pakkir, et al.
Publicado: (2022) -
Renin-Angiotensin-Aldosterone System (RAS) Inhibitors May Suppress the Prevalence of Peripheral Arterial Disease (PAD) in Elderly, Chronic Hemodialysis Patients
por: Tomaru, Ryo
Publicado: (2022) -
Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19)
por: Banwait, Ranjit, et al.
Publicado: (2021)